Literature DB >> 32889243

Association between NLR and COVID-19.

Serdar Kalemci1, Aydın Sarıhan2, Arife Zeybek3.   

Abstract

Entities:  

Keywords:  COVID-19 disease; Neutrophil-to-lymphocyte ratio; PLR

Mesh:

Year:  2020        PMID: 32889243      PMCID: PMC7437507          DOI: 10.1016/j.intimp.2020.106917

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


× No keyword cloud information.
We read with great interest the article recently published by Yang et al entitled “The diagnostic and predictive role of NLR, d-NLR and PLR in COVID-19 patients.” [1]. In this manuscript, the authors state that neutrophil-to-lymphocyte ratio (NLR) and advanced age can be used as independent biomarkers for indicating poor clinical outcomes. In this study, the mean age of the patients with severe clinical symptoms was 57.9 ± 11.8 years, and the mean age of non-severe patients was 42.1 ± 18.6 years. Age, is a parameter that affects NLR outcome [2]. In this study, we wonder whether NLR values were evaluated taking age into consideration. In addition, body mass index (BMI), physical activity, smoking, alcohol consumption and gender are the factors that may have an impact on NLR values [3]. We believe that these factors may have an effect on the results of the study.

CRediT authorship contribution statement

Serdar Kalemci: Conceptualization.
  1 in total

1.  Neutrophil-Lymphocyte ratio is associated with poor clinical outcome after mechanical thrombectomy in stroke in patients with COVID-19.

Authors:  Fawaz Al-Mufti; Priyank Khandelwal; Tolga Sursal; Jared B Cooper; Eric Feldstein; Krishna Amuluru; Jayaji M Moré; Ambooj Tiwari; Amit Singla; Adam A Dmytriw; Mariangela Piano; Luca Quilici; Guglielmo Pero; Leonardo Renieri; Nicola Limbucci; Mario Martínez-Galdámez; Miguel Schüller-Arteaga; Jorge Galván; Juan Francisco Arenillas-Lara; Zafar Hashim; Sanjeev Nayak; Keith Desousa; Hai Sun; Pankaj K Agarwalla; J Sudipta Roychowdhury; Emad Nourollahzadeh; Tannavi Prakash; Andrew R Xavier; J Diego Lozano; Gaurav Gupta; Dileep R Yavagal; Mohammad Elghanem; Chirag D Gandhi; Stephan A Mayer
Journal:  Interv Neuroradiol       Date:  2022-04-11       Impact factor: 1.610

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.